Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-08-31 20:54:19 - browse：788

A woman walks in San Francisco, with her father who has Alzheimer's – public health and science coverage from STAT — Ben Margot/AP

A host of hurdles are slowing the adoption of the new Alzheimer’s drug Leqembi, experts involved in the treatment of patients said Wednesday, from complicated logistics to the fact that many people don’t recognize that their memory loss is a disease soon enough.

Some patients still grapple with whether they want to be diagnosed, even though a treatment exists, the experts said, speaking during a STAT virtual event.

“Even the word for dementia does not always exist in every culture and in every language,” said Hollis Day, chief of geriatrics at Boston Medical Center and a professor at Boston University’s medical school. “And so just getting people to accept that memory loss is not normal aging necessarily, is a big barrier to getting people into diagnosis early enough to benefit from these treatments.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Solving academic medical centers' existential crisis

WSS

It's time to retire 'poor historian' from clinicians' vocabularies

Can we make enough H5N1 bird flu vaccine if there's a pandemic?

Second House panel advances two

Cytokinetics CEO stresses company can launch heart drug on its own

Arc Institute generative AI designs new CRISPR systems

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

hotspot

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

entertainment

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Readout LOUD podcast: Live from STAT Breakthrough Summit West

Anesthesiologist group: stop taking Ozempic before surgery

Make 'food is medicine' a key part of White House nutrition meeting

Alkermes shareholders re

Anxious about a speech? A startup wants you to pop a minty cardiac drug

Activists slam private health insurers over coverage restrictions

A new study asks: Are we harming blood donors by taking blood?

Activists slam private health insurers over coverage restrictions

Grail is spending more than ever lobbying Congress

focus

Russia says it foiled Ukrainian drone attack on Moscow as Kyiv's counteroffensive grinds on

Listen: Biogen's messy board & Laronde's data problem

Listen: PBM conflicts, RSV vaccines, & the future of flu season

Wearables generate powerful data but its not useful to doctors, yet

Can we make enough H5N1 bird flu vaccine if there's a pandemic?

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

Wikipedia

explore

focus

focus